Pacific Biosciences of California Debt to Equity Ratio:0.12 for Dec. 31, 2012
Pacific Biosciences of California Debt to Equity Ratio Chart
Pacific Biosciences of California Historical Debt to Equity Ratio DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|March 31, 2013||0.12|
|Dec. 31, 2012||0.00|
|Sept. 30, 2012||0.022|
|June 30, 2012||0.0193|
|March 31, 2012||0.0172|
|Dec. 31, 2011||0.00|
|Sept. 30, 2011||0.014|
|June 30, 2011||0.0128|
|March 31, 2011||0.0121|
|Dec. 31, 2010||0.0109|
|Sept. 30, 2010|
|June 30, 2010||0.0005|
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
PACB Debt to Equity Ratio Benchmarks
PACB Debt to Equity Ratio Rankings
1875 of 8002
300 of 650 in Healthcare
128 of 237 in Biotechnology
PACB Debt to Equity Ratio Range, Past 5 Years
Fool Apr 30